Twin Cities Clinical Research
Brooklyn Center, Minnesota, United States
Research foundation in Brooklyn Center, Minnesota
6200 Shingle Creek Pkwy #300, Brooklyn Center, MN 55430
About Twin Cities Clinical Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Twin Cities Clinical Research
During the past decade, Twin Cities Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
2009-11-01
2011-12-01
Completed
780
Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
2010-05-01
2012-10-01
Completed
78
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
2010-09-01
2011-12-01
Completed
180
Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris
2012-05-01
2013-05-01
Completed
37
A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel
2013-08-01
2014-06-01
Completed
114
Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
2013-12-01
2014-09-01
Completed
69
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
2015-05-01
2016-04-01
Completed
212
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Twin Cities Clinical Research" #1 sponsor was "Novartis" with 2 trials, followed by "Orexigen Therapeutics, Inc" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Dynavax Technologies Corporation"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Twin Cities Clinical Research"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Twin Cities Clinical Research
According to Clinical.Site data, the most researched conditions in "Twin Cities Clinical Research" are
"Chronic Renal Insufficiency" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hypertension" (2 trials), "Obesity" (2 trials) and "Overweight" (2 trials). Many other conditions were trialed in "Twin Cities Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Twin Cities Clinical Research
Most popular intervention types in "Twin Cities Clinical Research" are "Drug" (10 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ancillary therapy" (2 trials), "1018 ISS immunostimulatory oligonucleotide with HBV surface antigen" (1 trials), "CTAP101 Capsules" (1 trials) and "CTAP101 Injection" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Twin Cities Clinical Research
The vast majority of trials in "Twin Cities Clinical Research" are
11 trials for "All" genders.
Clinical Trials Status at Twin Cities Clinical Research
Currently, there are NaN active trials in "Twin Cities Clinical Research".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Twin Cities Clinical Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Twin Cities Clinical Research, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".